Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) Net Income towards Common Stockholders: 2022-2024

Historic Net Income towards Common Stockholders for Molecular Partners Ag (MOLN) over the last 3 years, with Dec 2024 value amounting to -$61.4 million.

  • Molecular Partners Ag's Net Income towards Common Stockholders rose 21.85% to -$14,796 in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.3 million, marking a year-over-year increase of 0.26%. This contributed to the annual value of -$61.4 million for FY2024, which is 10.99% up from last year.
  • Latest data reveals that Molecular Partners Ag reported Net Income towards Common Stockholders of -$61.4 million as of FY2024, which was up 10.99% from -$69.0 million recorded in FY2023.
  • Over the past 5 years, Molecular Partners Ag's Net Income towards Common Stockholders peaked at $122.3 million during FY2022, and registered a low of -$69.0 million during FY2023.
  • In the last 3 years, Molecular Partners Ag's Net Income towards Common Stockholders had a median value of -$61.4 million in 2024 and averaged -$2.7 million.
  • In the last 5 years, Molecular Partners Ag's Net Income towards Common Stockholders slumped by 156.42% in 2023 and then rose by 10.99% in 2024.
  • Yearly analysis of 3 years shows Molecular Partners Ag's Net Income towards Common Stockholders stood at $122.3 million in 2022, then crashed by 156.42% to -$69.0 million in 2023, then rose by 10.99% to -$61.4 million in 2024.